Larcaviximab
Larcaviximab (c4G7-N) is an IgG1 kappa anti-Ebola virus glycoprotein chimeric monoclonal antibody[1].
Product Specifications
CAS Number
1792982-56-9
Product Name Alternative
C4G7-N
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/larcaviximab.html
Purity
96.13
Solubility
H2O
Smiles
[Larcaviximab]
Molecular Weight
(144.96 kDa)
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 30, No. 4, 2016.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470760-500 1x 500 µL
Cytokeratin 7 (KRT7/760), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040287-500 1x 500 µL
Renal Cell Carcinoma (Carbonic Anhydrase IX) (66.4.C2), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881388-100 1x 100 µL
Ferritin, Light Chain (FTL) (Microglia Marker) (FTL/1388), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details